Aridis Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Issued from Q4 2017 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Aridis Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2017 to Q3 2023.
  • Aridis Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2023 was 44.6M shares, a 152% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 44.6M +26.9M +152% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 36.1M +18.4M +104% Jun 30, 2023 10-Q 2023-09-14
Q1 2023 36.1M +18.4M +104% Mar 31, 2023 10-Q 2023-06-08
Q4 2022 27M +9.33M +52.7% Dec 31, 2022 10-Q 2023-11-06
Q3 2022 17.7M +3.65M +26% Sep 30, 2022 10-Q 2022-11-21
Q2 2022 17.7M +6.47M +57.6% Jun 30, 2022 10-Q 2022-08-16
Q1 2022 17.7M +6.47M +57.6% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 17.7M +7.64M +75.9% Dec 31, 2021 10-K 2023-05-22
Q3 2021 14.1M +5.13M +57.5% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 11.2M +2.31M +25.9% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 11.2M +2.31M +25.9% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 10.1M +1.15M +12.9% Dec 31, 2020 10-K 2022-04-13
Q3 2020 8.92M +11.1K +0.13% Sep 30, 2020 10-Q 2020-11-23
Q2 2020 8.92M +816K +10.1% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 8.92M +816K +10.1% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 8.92M +814K +10% Dec 31, 2019 10-K 2021-03-30
Q3 2019 8.91M +808K +9.98% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 8.11M +7.94M +4773% Jun 30, 2019 10-Q 2019-08-12
Q1 2019 8.11M Mar 31, 2019 10-Q 2019-05-14
Q4 2018 8.1M +7.94M +4771% Dec 31, 2018 10-K 2020-04-08
Q3 2018 8.1M Sep 30, 2018 10-Q 2018-11-14
Q2 2018 166K Jun 30, 2018 10-Q 2018-09-26
Q4 2017 166K Dec 31, 2017 10-K 2019-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.